Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir for Genital Ulcers in African Women (ANRS 1212)
NCT00158483Phase 2Completed
- Sponsor
- ANRS
- Start
- May 2003
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in genital herpes comparing Acyclovir with Placebo (2 arms). Primary endpoints: Difference of HIV-1 RNA shedding assessed by performing cervicovaginal lavage (CVL) HIV viral load, Difference of HIV-1 DNA shedding assessed by performing cervicovaginal lavage (CVL) HIV viral load and 1 more. Started May 2003; status: completed.
02
Drugs
aciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00158483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158483.